Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Hackensack Meridian Health

Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 1
Sort by
  • New combo may Re-Sensitize Drug-Resistant myeloma

    Disease control Completed

    This study tested whether adding a drug called vorinostat to the standard combination of lenalidomide and dexamethasone could help people with multiple myeloma whose cancer had stopped responding to lenalidomide. The trial enrolled 25 patients with relapsed or refractory myeloma.…

    Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control

    Last updated Apr 29, 2026 05:15 UTC

  • Experimental drug shows promise for rare blood cancer

    Disease control Completed

    This study tested the drug carfilzomib in 7 people with Waldenström's macroglobulinemia, a rare blood cancer, that had come back after previous treatment. The goal was to see if the drug could shrink tumors and control the disease. Carfilzomib works by blocking a protein that cel…

    Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control

    Last updated Apr 29, 2026 05:14 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space